RARA
MOLECULAR TARGETretinoic acid receptor alpha
RARA (retinoic acid receptor alpha) is targeted by 135 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting RARA
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 135 compounds. Use the BiohacksAI search to explore all RARA modulators.
About RARA as a Drug Target
RARA (retinoic acid receptor alpha) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 135 compounds with documented RARA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
RARA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.